American International Group, Inc. Compass Therapeutics, Inc. Transaction History

American International Group, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$1.2 - $2.29 $463 - $883	-386 Reduced 0.85%	44,974 $89,000
Q4 2023 Feb 13, 2024	SELL	$1.4 - $1.98 $257 - $364	-184 Reduced 0.4%	45,360 $70,000
Q3 2023 Nov 13, 2023	BUY	$1.87 - $3.25 $3,029 - $5,265	1,620 Added 3.69%	45,544 $89,000
Q2 2023 Aug 04, 2023	BUY	$2.64 - $3.48 $115,959 - $152,855	43,924 New	43,924 $139,000

91.9M

Ticker CMPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 101,285,000
Market Cap $152M
Description
Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascula...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.